Literature DB >> 25425057

C/EBPβ LIP induces a tumor menagerie making it an oncogene.

Friedrich C Luft1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25425057     DOI: 10.1007/s00109-014-1224-4

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  18 in total

1.  CCAAT-enhancer-binding protein-beta expression in vivo is associated with muscle strength.

Authors:  Lorna W Harries; Luke C Pilling; L Dena G Hernandez; Rachel Bradley-Smith; William Henley; Andrew B Singleton; Jack M Guralnik; Stefania Bandinelli; Luigi Ferrucci; David Melzer
Journal:  Aging Cell       Date:  2012-01-13       Impact factor: 9.304

2.  A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation.

Authors:  C A Zahnow; R D Cardiff; R Laucirica; D Medina; J M Rosen
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

3.  Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer.

Authors:  C A Zahnow; P Younes; R Laucirica; J M Rosen
Journal:  J Natl Cancer Inst       Date:  1997-12-17       Impact factor: 13.506

4.  C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells.

Authors:  Roger R Gomis; Claudio Alarcón; Cristina Nadal; Catherine Van Poznak; Joan Massagué
Journal:  Cancer Cell       Date:  2006-09       Impact factor: 31.743

5.  Translational control of C/EBPalpha and C/EBPbeta isoform expression.

Authors:  C F Calkhoven; C Müller; A Leutz
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

6.  CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture.

Authors:  L M Bundy; L Sealy
Journal:  Oncogene       Date:  2003-02-13       Impact factor: 9.867

7.  A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer.

Authors:  Justin Lamb; Sridhar Ramaswamy; Heide L Ford; Bernardo Contreras; Robert V Martinez; Frances S Kittrell; Cynthia A Zahnow; Nick Patterson; Todd R Golub; Mark E Ewen
Journal:  Cell       Date:  2003-08-08       Impact factor: 41.582

8.  Novel mechanism of C/EBP beta (NF-M) transcriptional control: activation through derepression.

Authors:  E Kowenz-Leutz; G Twamley; S Ansieau; A Leutz
Journal:  Genes Dev       Date:  1994-11-15       Impact factor: 11.361

9.  The NF-M transcription factor is related to C/EBP beta and plays a role in signal transduction, differentiation and leukemogenesis of avian myelomonocytic cells.

Authors:  S Katz; E Kowenz-Leutz; C Müller; K Meese; S A Ness; A Leutz
Journal:  EMBO J       Date:  1993-04       Impact factor: 11.598

10.  Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice.

Authors:  I Screpanti; L Romani; P Musiani; A Modesti; E Fattori; D Lazzaro; C Sellitto; S Scarpa; D Bellavia; G Lattanzio
Journal:  EMBO J       Date:  1995-05-01       Impact factor: 11.598

View more
  4 in total

1.  Mdm2 promotes myogenesis through the ubiquitination and degradation of CCAAT/enhancer-binding protein β.

Authors:  Dechen Fu; Neena Lala-Tabbert; Hwabin Lee; Nadine Wiper-Bergeron
Journal:  J Biol Chem       Date:  2015-02-26       Impact factor: 5.157

Review 2.  uORF-mediated translational control: recently elucidated mechanisms and implications in cancer.

Authors:  Hung-Hsi Chen; Woan-Yuh Tarn
Journal:  RNA Biol       Date:  2019-06-24       Impact factor: 4.652

3.  Microarray data analysis to identify crucial genes regulated by CEBPB in human SNB19 glioma cells.

Authors:  Chenghua Du; Pan Pan; Yan Jiang; Qiuli Zhang; Jinsuo Bao; Chang Liu
Journal:  World J Surg Oncol       Date:  2016-10-06       Impact factor: 2.754

Review 4.  Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates.

Authors:  Silvia Belluti; Giovanna Rigillo; Carol Imbriano
Journal:  Cells       Date:  2020-03-20       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.